semaglutide blindness Popular weight loss and diabetes drugs linked to increased risk of rare form of Ozempic, Wegovy may be linked

Primary Finding: Weekly semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE: cardiovascular death, non-fatal MI, or non-fatal stroke) by 20% compared with placebo (HR 0.80, 95% CI 0.720.90)

Located in Lewisburg, Pennsylvania Call us or request your consultation online to begin

GLP-1 drugs linked to reduced risk of epilepsy A retrospective analysis of data from adults treated for type-2 diabetes indicates that glucose-lowering GLP-1 drugs could be linked to a lower risk of epilepsy

( a , b ) Cumulative distribution plot of observed percentage change from baseline over time in body weight for participants in the full analysis set during the in-trial observation period* (a) and on-treatment observation period (b)

Quick & Painless Injections : The shots are administered in just a few minutes, making them a convenient addition to your weekly routine